We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
HyperionDev teaches people to code through online courses overseen by top code reviewers. It asserts that its core innovation was efficiently connecting top students to struggling ones having them review code on structured courses. This led to HyperionDev being financially backed by technology giants Facebook and Google in 2016/17 helping the company scale its computer-assisted code review process. HyperionDev has registered over 150,000 students and onboarded clients like Lambda School and Makers. The company reached profitability in 2020 earning £1 million in revenue and more than 250% user growth. It will use the investment to commercialise its model in the $300 billion tech education and assessments market and close the tech skills gap.

Pitch Rated

86%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,999,998
Lenderwize is the first lending platform for Telecom Operators, offering investment opportunities in a new Asset Class. Its typical clients are mid-sized operators with an annual revenue of 50-300 million USD. Lenderwize sells to large Tier1 Operators (Originators) and buys from smaller (Terminating) Operators. Thanks to Lenderwize's in-depth industry knowledge, they have identified 1350 wholesalers in need of $96 million, making the Cost of Acquisition of clients very low. Additionally, its lean Back Office, Credit Vetting and Loan Management gives Lenderwize a competitive edge over Market Invoice or Funding Circle. With the funds, the company will invest in technology development and integration, increasing sales, marketing activities, and recruitment to enhance its reach globally.

Pitch Rated

86%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £100,045
Lumio is an intelligent and independent application that intends to help people grow their money on autopilot. Lumio argues that £176 billion of lazy money is depreciating in the UK while for Europe, that number stands at £10 trillion. Lumio aims to optimise this money for everyone so that everyone can gain access to financial security and decide their financial future. The company claims that over £90 million worth of user transactions has been analysed by its smart algorithm. It has more than 6000 users on iOS and Android, which is growing 20% monthly. Lumio was recognised as part of the 'Top 100 Fintech Disruptor' by BusinessCloud in 2020, ahead of Monzo and Seedrs. It has also featured in Forbes, Tech Nation and Sifted by FT. It will use the investment to grow 1 million customers' money by 2024 and accelerate financial independence and personal progress through its technology.

Pitch Rated

85%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,149,659
Drop is a tech-enabled on-demand virtual wine cellar that delivers quality wine to a customer's doorstep within 1 hour. The company asserts that 25% of the UK's 28 million regular wine drinkers are now buying online. Drop feels that its portal is well-equipped to fulfill the demands of its audience. Its app is available on the App Store and Google Playstore. The company has fulfilled over 25,000 orders to over 4,000 customers with over 750 customers having ordered over five times. Drop will use the investment towards technology development, boost its business, and fuel company growth.

Pitch Rated

85%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £533,380
Artfinder is the art world's first certified B corporation that is on a mission to create a world where art benefits everyone. Operating in the $55 billion+ wall décor and online art market, the company is backed by Wellington Partners, and private investors in the UK, US and Switzerland. It has 60,000 customers, 6,000 artists and a collection of 470,000 artworks. The company believes in establishing direct contact with artists to select or commission work and negotiate prices. Customers have rated the company highly with 4.8+ Trustpilot reviews. The company will use the investment to supercharge its growth, grow its team and improve its platform.

Pitch Rated

85%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £834,056
Football Fan (FF) aims to become the go-to app for anything Football. FF asserts that Football (Soccer) is a dynamic all year sport with 4+ billion football fans generating business opportunities like merchandising, advertising, ticketing, gaming, travel, streaming, and more. FF believes that these fan bases are diluted on many platforms to meet their daily Football needs. FF aspires to change this by offering a blend of SportsTech with business opportunities supported by fan-engagement features on its app. Fans can connect with other fans or their club, create stories, watch videos, follow live scores, in-game events and statistics, post opinions/reactions, use banter rooms, and more. The app also rewards fans with FanCoins based on their contribution. FF app has witnessed over 22,000 downloads with 1.5 million+ interactions since its launch in June 2020. The company will use the investment to fuel user growth, starting with an initial focus on English Football and its fandom.

Pitch Rated

85%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £320,853
Medic Bleep is a secure and real-time communication solution that aims to help medical teams communicate and collaborate effectively, reduce costs, and improve patient outcomes. It argues that poor inter-team communication has led to an estimated 400,000 episodes of potential harm a year, in the National Health Service (NHS) alone. Medic Bleep aspires to change this. It points out that its services have saved an average of £2.5 million worth of potential harm expenses per NHS Trust. The company asserts that its services are now being used by 5,600+ staff across hospitals every month. Medic Bleep has partnered with the BT Group targeting 20% of NHS trusts by 2025. It has 5,600 monthly active users and has witnessed 18,000 app downloads on multiple platforms. The company will use the investment to develop Version 2 of its product, deliver on its BT contract and NHS X framework to increase sales, and explore other geographies.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £455,375
miiCARE is a MedTech specialising in AI applied to geriatrics (elderly care). Its key product miiCUBE offers cutting-edge home-based and customised healthcare, helping the elderly enjoy their independence while being comprehensively connected to their families, friends, and neighbours. The company aims to provide these benefits to one billion people by 2028, comprising older people, family members and carers. Till date, miiCARE has secured partnerships with the UK’s largest NHS trust, Ebbsfleet Garden City, O2, Bristol Careline and Microsoft, and won multiple social impacts and digital health awards during the last 12 months. Funds raised will be used mainly for fulfilling pre-orders and close interests for large contracts with corporates, marketing and logistics, product development, sales and salaries.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £103,672
Zone V makes the latest tablets and smartphones work for the older generation with low eyesight, deficient hearing or dexterity. The company has redefined a global platform that is providing access to the services that are difficult to use. They have a technological partnership with Samsung and are a Samsung Managed Solutions Partner. The company also creates inclusively accessible technology, services, and applications for more smoother and viable communication. The executive team of this company includes health, telecoms, and wellness fields. With the proceeds, Zone V will widen the digital divide for the older smartphones users by working tirelessly to build new innovative communication solutions.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £500,000
Gendius is a company that aims to bring pharmaceuticals and health economics, through clinical research and evidence, to the mobile health market. Their latest innovation, Intellin, is an intelligent remote management diabetes platform, with over 140,000 downloads so far. The COVID-19 crisis has highlighted the need for remote home monitoring of patients, and the company feels that its product is a suitable contender in this domain. Intellin has a reliable connection to over 150 medical devices and apps, and also consists of a two-way communication setup with a healthcare professional via a secure dashboard. Gendius is registered as an approved vendor with AstraZeneca in Saudi Arabia and looks to establish deeper relations with the National Health Service (UK) to create a demand for its product. The company will use the investment to scale its business globally, drive commercialisation, offer an opportunity to its stakeholders, and target venture capital.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £386,829
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph